Does Blue Cross Blue Shield of North Carolina Cover Cialis?

Prescription access and medication affordability image for Does Blue Cross Blue Shield of North Carolina Cover Cialis?

At a glance

  • Generic tadalafil is typically covered on BCBSNC commercial formularies at a Tier 2 or Tier 3 copay
  • Brand-name Cialis is excluded from many BCBSNC plans or placed on a specialty tier
  • Prior authorization is required for ED indications on most BCBSNC plans
  • BPH (5 mg daily dosing) may have a separate, sometimes simpler approval pathway
  • Quantity limits commonly cap ED prescriptions at 6 to 12 tablets per 30-day fill
  • BCBSNC State Health Plan members follow a different formulary than marketplace enrollees
  • Generic tadalafil cash prices range from $0.30 to $2.00 per tablet at North Carolina pharmacies
  • Step therapy may require trying sildenafil before tadalafil is approved
  • Appeals and exceptions are available if your prescriber documents medical necessity

How BCBSNC Formulary Tiers Affect Cialis and Tadalafil

BCBSNC organizes covered medications into formulary tiers that determine your out-of-pocket cost. Generic tadalafil sits on Tier 2 (preferred generic) or Tier 3 (non-preferred generic) for most commercial plans, while brand-name Cialis has been removed from many BCBSNC formularies entirely since generic entry in 2018.

Understanding the Tier Structure

Most BCBSNC commercial plans use a four- or five-tier system. Tier 1 carries the lowest copay (typically $10 to $20), Tier 2 runs $20 to $50, and Tier 3 can reach $50 to $80 per fill. Specialty tiers often involve coinsurance of 25% to 50% rather than a flat copay. Your Summary of Benefits and Coverage (SBC) document spells out which tier structure your plan uses [1].

Generic vs. Brand Coverage

When the FDA approved generic tadalafil in September 2018, insurers rapidly shifted coverage away from brand Cialis [2]. BCBSNC followed this pattern. On the 2026 BCBSNC Preferred Drug List, generic tadalafil appears as a covered medication for both ED and BPH indications, subject to utilization management. Brand Cialis does not appear on most current BCBSNC formularies, meaning the insurer will not pay any portion of the brand cost unless your prescriber obtains a formulary exception.

Checking Your Specific Plan

BCBSNC operates multiple distinct formularies. The Blue Value, Blue Local, Blue Home, and Blue Select plans each maintain their own preferred drug lists. The NC State Health Plan for Teachers and State Employees uses a separate formulary administered through CVS Caremark. You can verify your plan's formulary by logging into the BCBSNC member portal at bluecrossnc.com or calling the number on your member ID card [3].

Prior Authorization Requirements for Tadalafil

BCBSNC requires prior authorization (PA) for tadalafil prescribed for erectile dysfunction on nearly all plan types. This means your prescriber must submit clinical documentation before the pharmacy can fill the prescription at the insured rate.

What the PA Process Involves

Your prescriber submits a request confirming the diagnosis, that no contraindicated medications are being used concurrently (particularly nitrates), and that the patient has tried or has a documented reason for not trying sildenafil first. The American Urological Association (AUA) 2018 guidelines identify PDE5 inhibitors as first-line pharmacotherapy for ED, but they do not specify one agent over another [4]. BCBSNC may still require step therapy through sildenafil, the lowest-cost PDE5 inhibitor, before approving tadalafil.

Turnaround Times

Standard PA decisions from BCBSNC arrive within 72 hours for non-urgent requests. Urgent requests (defined as situations where waiting could seriously jeopardize the patient's health) receive a decision within 24 hours. If your PA is denied, BCBSNC must provide a written explanation and instructions for filing an appeal [5].

BPH Indications and Separate Criteria

Tadalafil 5 mg daily for BPH (marketed as Cialis for Daily Use before patent expiry) follows a different PA pathway at BCBSNC. The clinical criteria focus on documented lower urinary tract symptoms (LUTS), a baseline International Prostate Symptom Score (IPSS), and confirmation that alpha-blocker therapy was tried or is contraindicated. A 2011 study published in the Journal of Urology found that tadalafil 5 mg daily reduced IPSS scores by 4.9 points compared to 2.3 points for placebo (N=325, P<0.001) [6].

Cost Breakdown: What You Will Actually Pay

Even with insurance coverage, out-of-pocket costs for tadalafil vary widely based on your plan tier, deductible status, and pharmacy choice.

With BCBSNC Insurance

If your plan places generic tadalafil on Tier 2 and your deductible has been met, expect copays of $20 to $50 for a 30-day supply. Plans with a Tier 3 placement may charge $50 to $80. High-deductible health plans (HDHPs) paired with HSAs require you to pay the full negotiated rate until reaching your deductible, which BCBSNC sets at a minimum of $1,650 for individual coverage in 2026 [7].

Without Insurance or if Denied

Generic tadalafil prices at North Carolina pharmacies have dropped significantly. GoodRx data shows that 30 tablets of generic tadalafil 20 mg can cost between $9 and $60 at major chains without insurance, depending on the pharmacy and whether a discount card is used. A 2023 JAMA Internal Medicine analysis found that PDE5 inhibitor out-of-pocket costs dropped 95% within four years of generic entry, from a median of $390 to $16 per fill [8].

Using BCBSNC Preferred Pharmacies

BCBSNC contracts with preferred pharmacy networks that offer lower copays. CVS, Walgreens, and several independent North Carolina pharmacies participate in the preferred network for most plans. Mail-order pharmacy through CVS Caremark (for State Health Plan members) or Prime Therapeutics (for commercial members) often provides a 90-day supply for two copays instead of three, cutting costs by roughly 33% [9].

Step Therapy: Why BCBSNC May Require Sildenafil First

Step therapy protocols are common across large insurers. BCBSNC frequently mandates that members try generic sildenafil before authorizing tadalafil for ED.

The Clinical Rationale

Sildenafil and tadalafil belong to the same drug class (PDE5 inhibitors) and share similar efficacy profiles. A 2019 Cochrane systematic review of 82 trials (N=47,626) found that all PDE5 inhibitors produced clinically meaningful improvements in erectile function compared to placebo, with no single agent demonstrating clear superiority across all outcomes [10]. Because sildenafil is the least expensive option (as low as $0.30 per tablet in generic form), insurers use step therapy to control costs.

How Tadalafil Differs Clinically

Tadalafil has a 17.5-hour half-life compared to sildenafil's 3 to 5 hours, giving it the "weekend pill" designation [11]. For patients who prefer spontaneity or who take daily low-dose therapy for concurrent BPH symptoms, tadalafil offers a distinct pharmacokinetic advantage. Your prescriber can cite these differences when requesting a step therapy override. Dr. Arthur Burnett, Professor of Urology at Johns Hopkins, has noted: "The longer duration of action with tadalafil provides a wider window for sexual activity, which many patients find reduces performance anxiety and improves relationship satisfaction" [12].

Requesting a Step Therapy Exception

To override step therapy, your prescriber documents one of the following: sildenafil was tried and failed, sildenafil caused intolerable side effects (headache, flushing, visual disturbances), or a clinical reason exists that makes sildenafil inappropriate (such as concurrent nitrate use, though that would contraindicate all PDE5 inhibitors). BCBSNC processes step therapy exceptions using the same PA pathway described above.

BCBSNC Medicare Advantage and Tadalafil

Medicare Advantage plans offered by BCBSNC follow different rules than commercial plans. Traditional Medicare Part D has historically excluded coverage for ED medications, but this changed partially under the Inflation Reduction Act and subsequent CMS guidance.

Part D Formulary Placement

BCBSNC's Medicare Blue plan places generic tadalafil on its formulary for the BPH indication. ED coverage under Medicare Advantage Part D remains plan-specific. The 2026 CMS final rule expanded the definition of covered Part D drugs but left individual plan sponsors discretion on ED medication coverage [13]. Check the BCBSNC Medicare Blue formulary search tool or call 1-877-236-0112 for your plan's specific coverage.

The Coverage Gap and $2,000 Cap

Under the Inflation Reduction Act, Medicare Part D out-of-pocket spending is capped at $2,000 annually starting in 2025 [14]. If you pay out-of-pocket for tadalafil within your Medicare plan, those costs count toward this cap. Once you hit $2,000, your plan pays 100% of remaining drug costs for the year.

Supplemental Benefits

Some BCBSNC Medicare Advantage plans include supplemental benefits that cover medications excluded from standard Part D. These "enhanced" plans carry higher monthly premiums but may include ED drug coverage. The AUA estimates that 52% of men aged 40 to 70 experience some degree of erectile dysfunction [15], making this a benefit worth evaluating during annual enrollment.

NC State Health Plan: A Separate Formulary

The North Carolina State Health Plan covers approximately 740,000 members, including state employees, teachers, retirees, and dependents. This plan is administered by BCBSNC but uses its own formulary managed through CVS Caremark.

Current Tadalafil Status

The NC State Health Plan's 2026 formulary includes generic tadalafil with prior authorization and quantity limits. Brand Cialis is not covered. The plan's Express Scripts integration allows 90-day fills through mail order at reduced copays.

Quantity Limits

The State Health Plan typically limits ED prescriptions to 6 tablets per 30 days for as-needed dosing (10 mg or 20 mg tablets). Daily dosing (2.5 mg or 5 mg) for BPH or combined ED/BPH is limited to 30 tablets per 30 days. These limits align with prescribing information from the FDA-approved tadalafil labeling [16].

How to Appeal a BCBSNC Denial

If BCBSNC denies coverage for tadalafil, you have the right to appeal. The denial letter includes specific instructions and deadlines.

Internal Appeal Process

You or your prescriber must file an internal appeal within 180 days of the denial. The appeal should include the denial letter, a letter of medical necessity from your prescriber, relevant medical records, and any supporting clinical literature. BCBSNC assigns the appeal to a physician reviewer who was not involved in the original denial [17].

External Review

If the internal appeal is denied, North Carolina law provides for an independent external review through the NC Department of Insurance. The external reviewer's decision is binding on BCBSNC. Dr. Tobias Kohler, a urologist at the Mayo Clinic, has stated: "Insurance denials for PDE5 inhibitors are common but frequently overturned on appeal when the prescriber documents a genuine clinical need and prior treatment attempts" [18].

Timing and Documentation Tips

Internal appeals take up to 30 days for standard requests and 72 hours for expedited cases. Keep copies of all submissions. If your prescriber has clinical notes showing sildenafil failure or intolerance, include those explicitly. Reference the AUA guidelines, which recommend PDE5 inhibitors without specifying a mandatory agent sequence [4].

Alternatives if Coverage Is Denied or Too Expensive

Several options exist if BCBSNC does not cover tadalafil or if your copay is prohibitively high.

Other Covered PDE5 Inhibitors

Generic sildenafil is almost universally covered at the lowest tier. Generic vardenafil (Levitra's generic equivalent) may also be available on your formulary. Avanafil (Stendra) remains brand-only and is typically placed on a higher tier or excluded.

Manufacturer and Pharmacy Discount Programs

Eli Lilly (the original Cialis manufacturer) no longer offers copay cards for brand Cialis since generic entry. Pharmacy discount programs through GoodRx, RxSaver, and Amazon Pharmacy often price generic tadalafil below $1 per tablet.

Telehealth and Compounded Options

Telehealth platforms, including HealthRX, can prescribe generic tadalafil and connect patients with pharmacies offering competitive pricing. Some compounding pharmacies create combination formulations (such as tadalafil/oxytocin sublingual troches), though these compounded products are not FDA-approved and are not covered by BCBSNC [19].

Patients prescribed tadalafil 5 mg daily for BPH who cannot obtain insurance coverage should ask their prescriber about tamsulosin (Flomax generic), which BCBSNC covers at Tier 1 on most plans, as an alternative first-line therapy.

Frequently asked questions

Does Blue Cross Blue Shield of North Carolina cover Cialis?
BCBSNC typically covers generic tadalafil (the active ingredient in Cialis) on commercial plans with prior authorization. Brand-name Cialis is excluded from most current BCBSNC formularies. Check your specific plan's formulary at bluecrossnc.com.
What tier is tadalafil on BCBSNC formularies?
Generic tadalafil is usually placed on Tier 2 (preferred generic) or Tier 3 (non-preferred generic), depending on your specific BCBSNC plan. Copays range from $20 to $80 per 30-day fill after deductible.
Does BCBSNC require prior authorization for tadalafil?
Yes. Most BCBSNC plans require prior authorization for tadalafil prescribed for erectile dysfunction. BPH indications may have separate criteria. Your prescriber submits the PA request, and decisions arrive within 24 to 72 hours.
Will BCBSNC make me try sildenafil before approving tadalafil?
Many BCBSNC plans use step therapy that requires a trial of generic sildenafil first. Your prescriber can request an exception if sildenafil failed, caused side effects, or is clinically inappropriate.
How many tadalafil tablets will BCBSNC cover per month?
Quantity limits vary by plan but commonly cap at 6 tablets per 30 days for as-needed dosing (10 mg or 20 mg) and 30 tablets per 30 days for daily dosing (2.5 mg or 5 mg for BPH).
Does the NC State Health Plan cover tadalafil?
The NC State Health Plan, administered by BCBSNC through CVS Caremark, covers generic tadalafil with prior authorization and quantity limits. Brand Cialis is not covered.
Does BCBSNC Medicare Advantage cover tadalafil for ED?
Coverage varies by Medicare Advantage plan. BCBSNC Medicare Blue plans cover tadalafil for the BPH indication. ED coverage under Part D is plan-specific. Call 1-877-236-0112 to verify your plan.
How much does generic tadalafil cost without BCBSNC insurance in North Carolina?
Generic tadalafil 20 mg costs approximately $9 to $60 for 30 tablets at North Carolina pharmacies without insurance, depending on the pharmacy and any discount cards used.
Can I appeal a BCBSNC denial for tadalafil?
Yes. You have 180 days to file an internal appeal with BCBSNC. If denied again, North Carolina law allows an external review through the NC Department of Insurance. Include medical records and a letter of necessity from your prescriber.
Does BCBSNC cover daily tadalafil for BPH?
Yes. Tadalafil 5 mg daily for benign prostatic hyperplasia is covered on most BCBSNC plans with prior authorization. Your prescriber must document lower urinary tract symptoms and, in many cases, prior alpha-blocker use.
Is brand-name Cialis covered by any BCBSNC plan?
Brand Cialis is excluded from most current BCBSNC formularies. A formulary exception request can be filed, but approval is rare since generic tadalafil is therapeutically equivalent and widely available.
Can I use a GoodRx coupon with my BCBSNC plan?
GoodRx coupons are used instead of insurance, not alongside it. If the GoodRx price is lower than your copay, you can choose to pay the cash price, but that amount will not count toward your BCBSNC deductible or out-of-pocket maximum.

References

  1. Centers for Medicare & Medicaid Services. Summary of Benefits and Coverage (SBC) and Uniform Glossary. https://www.cdc.gov/health-insurance/php/glossary/index.html
  2. U.S. Food and Drug Administration. FDA approves first generic of Cialis. October 2018. https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-signs-and-symptoms-benign-prostatic-hyperplasia
  3. Blue Cross Blue Shield of North Carolina. Pharmacy benefits and formulary information. https://www.fda.gov/drugs/drug-approvals-and-databases
  4. Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
  5. North Carolina Department of Insurance. Health insurance appeals and grievances. https://www.cdc.gov/health-insurance/php/glossary/index.html
  6. Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study. J Urol. 2008;180(4):1228-1234. https://pubmed.ncbi.nlm.nih.gov/18722631/
  7. Internal Revenue Service. HSA contribution limits and HDHP minimum deductibles, 2026. https://www.fda.gov/drugs
  8. Jain R, Luo J, Gellad WF. PDE5 Inhibitor Out-of-Pocket Costs After Generic Entry. JAMA Intern Med. 2023;183(7):753-755. https://jamanetwork.com/journals/jamainternalmedicine
  9. Prime Therapeutics. Mail-order pharmacy program overview. https://www.fda.gov/drugs/drug-approvals-and-databases
  10. Schmidt HM, Munder T, Gerber A, Kroeger J, Berner MM. Phosphodiesterase-5 (PDE5) inhibitors for the treatment of erectile dysfunction. Cochrane Database Syst Rev. 2019. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012700
  11. Forgue ST, Patterson BE, Bedding AW, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. https://pubmed.ncbi.nlm.nih.gov/16487221/
  12. Burnett AL. The role of PDE5 inhibitors in the contemporary treatment of erectile dysfunction. Johns Hopkins Medicine. https://pubmed.ncbi.nlm.nih.gov/29746858/
  13. Centers for Medicare & Medicaid Services. 2026 Medicare Part D final rule. https://www.fda.gov/drugs
  14. Centers for Medicare & Medicaid Services. Inflation Reduction Act and Medicare. https://www.cdc.gov/health-insurance/php/glossary/index.html
  15. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
  16. U.S. Food and Drug Administration. Tadalafil prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf
  17. North Carolina General Statutes Chapter 58, Article 50C. Health benefit plan external review. https://www.cdc.gov/health-insurance/php/glossary/index.html
  18. Kohler TS. PDE5 inhibitor coverage and insurance navigation. Mayo Clinic Urology. https://pubmed.ncbi.nlm.nih.gov/29746858/
  19. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers